16th August 2022
16th August 2022
BioImpact Capital Announces Multi-Billion Dollar Landmark Transaction in Vaccines and Cancer
16th August 2022
Merck and Orna Therapeutics Collaborate to Advance Orna’s Next Generation of RNA Technology
16th August 2022
Orna Therapeutics Raises $221 Million Series B Financing to Advance Circular RNA Platform, Accelerate Programs to the Clinic
2nd June 2022
The Health of Life Sciences Investment Climate — Chris Bardon (GBR Capital Interview)
2nd June 2022